Snail, Cica, Propolis, PDRN: Korea Runs a Hype Cycle, and You Can Read It Early

The conveyor is real, and it has a timetable

The sequence is consistent enough to set a watch by. An active appears in Korean products. Korean consumers — an unusually engaged, unusually fast-moving market with high product turnover — adopt it at scale, and the informal stress-testing that follows is more thorough than most clinical programmes because the sample size is a country. Two to three years later the ingredient appears in Western brands, generally at several times the price, framed as a discovery.

The useful thing about a pattern that regular is that it can be read forward rather than only backward. If you know what tends to survive the trip and what tends to die on the way, you can evaluate the next arrival while it is still an unfamiliar word on a Korean label — which is precisely when the price is lowest and the marketing has not yet been written.

Four ingredients have now completed enough of the cycle to serve as case studies, and they fail and succeed in usefully different ways. One has a devoted following and almost no evidence. One had real evidence and got diluted on the way. One demonstrated that an ingredient name is not a specification. And one is mid-flight right now, with a problem you can see coming.

Snail mucin: a decade of popularity, and the file never filled in

Snail secretion filtrate is the longest-running case. It reached Western awareness around the middle of the last decade, largely through a single essence that became the category's ambassador, and it has never really left.

The mechanistic story is appealing: the secretion contains glycosaminoglycans, glycoproteins, hyaluronic acid and antioxidant components, and laboratory work has looked at fibroblast proliferation and matrix effects. As a formulation ingredient it behaves well — a humectant and film-former that leaves a distinctive slip and genuinely improves the feel of dehydrated skin.

What has not happened, in more than ten years of mass use, is a body of controlled human trials supporting the claims made for it. The study most often cited in support concerns a mollusk egg-derived ingredient rather than snail secretion filtrate, which is a different material from a different part of a different process. There is no good clinical evidence that it repairs acne scarring, and our ↗answer on that specific question goes into why the claim persists anyway.

So the honest verdict on ↗COSRX Advanced Snail 96 Mucin Power Essence and its many relatives is: a pleasant, effective hydrating layer with an unusually loyal following and a research file that a decade of popularity has not filled. That is not a condemnation — it is a competent product doing a modest job. It is a warning about what popularity does not prove. ↗The snail mucin page carries the grading, and ↗our ranking assesses the formulas rather than the folklore.

The lesson for reading the next ingredient: mass adoption generates enormous safety information and almost no efficacy information. Ten years of people liking something tells you it is tolerable. It does not tell you it works.

Centella: the case where the hype was pointing at something

Centella asiatica — cica — arrived on the conveyor a few years behind snail and behaved differently, because it came with a constituent rather than only a source.

The activity sits in a group of triterpenes: asiaticoside, madecassoside, asiatic acid and madecassic acid. There is a genuine topical literature examining centella in wound healing, with mechanisms including collagen synthesis and antioxidant activity, and a pharmaceutical-grade titrated extract standardised to a defined triterpene content exists as a distinct material. That is a meaningfully stronger position than snail ever occupied.

The complication is what happened during the trip. The pharmaceutical evidence attaches to standardised material at studied concentrations; a large share of cosmetic cica products use unstandardised extract at levels well below one percent, and the evidence does not transfer with the plant name. A product such as ↗SKIN1004 Madagascar Centella Ampoule is trading on a real ingredient class, but whether any given jar is delivering a meaningful triterpene dose is not something the label will tell you.

Centella is also the case where the Western copy was sometimes genuinely better rather than merely more expensive — because brands entering later, into a market with more sophisticated claims scrutiny, more often bought the standardised material and stated what was in it. That is worth remembering the next time the reflexive advice is to buy the original.

↗The centella page sets out where the evidence is strong and where it thins, and it is the single best example on this list of an ingredient whose hype was, unusually, aimed at the right target.

Propolis: the case that proves a name is not a specification

Propolis moved through the cycle around the end of the last decade and produced the most instructive complication of the four, because it generated a clinical signal on the way.

Propolis was added to the European baseline patch test series in 2019. A university centre in Amsterdam subsequently tested more than three thousand consecutive patients and found 9.5 percent positive to it — a very high figure for a baseline allergen. The honest reading of that number is more interesting than the number: only about three percent of those reactions were judged clinically relevant, and most were probably cross-reactions in people already sensitised to fragrance markers and balsam of Peru. The authors concluded that propolis in the baseline series had limited value for their population, which is a corrective worth absorbing before anyone builds a scare campaign out of a positivity rate.

But the detail buried in that study is the one that should change how you read every botanical label you ever see again. Positive reactions rose steeply between 2020 and 2023 — and the authors attributed this, most likely, to the manufacturer of the patch test material replacing Chinese propolis with Brazilian propolis.

Same ingredient name. Same test. Different bees, different plants, different resin chemistry, measurably different allergenicity. Nobody was deceiving anyone; the substitution simply happened upstream, as substitutions do.

That is the general principle. A biological ingredient name specifies a source, not a composition, and the composition can change without the label changing. ↗The propolis page covers where the real risk sits, and a propolis formula like ↗COSRX Full Fit Propolis Light Ampoule should be judged on how your own skin responds rather than on either the enthusiasm or the alarm attached to the category.

PDRN: the case in flight, with a visible problem

Polydeoxyribonucleotide is the ingredient currently mid-conveyor, and if you want to practise reading one early, this is the live exercise.

The underlying material is fragmented DNA, historically from salmon, and there is real clinical interest in it. Reviews describe a mechanism running through adenosine A2A receptor activation, with a body of work on impaired wound healing, and narrative reviews now cover its use in post-procedure recovery in aesthetic medicine. In Korea it is widely used as an injectable in the treatments marketed as skin boosters, and that is where the evidence sits.

Which is the first problem, and it is a route-of-administration mismatch of exactly the kind that catches people out. Evidence for injected material does not transfer to a serum. DNA fragments are large, highly hydrophilic polymers, and the stratum corneum is specifically evolved to exclude large hydrophilic molecules. Whether a topical PDRN preparation delivers meaningful quantities of intact polymer to living tissue is an unresolved question, not a settled one, and the cosmetic marketing does not distinguish between the injected literature and the jar.

The second problem is the propolis problem arriving early. Recent published work describes polydeoxyribonucleotide derived from Panax ginseng adventitious root, from Chlorella protothecoides, and from Gynostemma pentaphyllum callus. Plant and algal PDRN is a genuine research direction with its own rationale — but it means the word on your label may not describe salmon at all, and the fragment length, purity and composition differ by source. The substitution is happening in real time, in public, before the topical evidence base even exists.

None of that makes ↗COSRX 5 PDRN Collagen Intense Vitalizing Serum or ↗Anua PDRN Hyaluronic Acid Capsule 100 Serum bad products — both are competently built hydrating formulas that will behave well on most skin. It means you should buy them for the formula around the PDRN and treat the headline ingredient as unproven in this format. ↗The PDRN page tracks the evidence as it develops.

Four questions to ask the next one

The point of tracing a conveyor is to stop having to adjudicate each arrival from scratch. Four questions do most of the work, and all four are answerable before any trial exists.

Does it name a constituent, or only a source? An ingredient with an identified active molecule — a triterpene, a polyphenol, a defined fragment — can be standardised, dosed and studied. An ingredient identified only by what it came from cannot, and its evidence file will stay thin no matter how popular it becomes. This single question separates centella from snail.

Is there a route-of-administration mismatch? When the impressive evidence is for an injected, oral or professionally-applied version and the product is a leave-on cosmetic, the evidence is not transferable and the marketing is relying on you not noticing. This is PDRN's problem, and it is a very common one.

Can the molecule plausibly get where it needs to be? Large, hydrophilic and polymeric are three strikes against crossing intact stratum corneum. That does not make a product useless — surface humectancy and film-forming are real benefits — but it should reset which claims you accept.

And is the source variable? A biological name specifies origin, not composition. If the material can come from different species, regions or processes, then batch, brand and year all matter, and your own tolerance is the only test that counts.

On the buy-the-original-or-the-copy question, the honest answer is that it depends on which failure you are avoiding. The Korean original is usually cheaper and closer to the formulation culture that developed the ingredient. The Western adaptation is sometimes better because it more often uses standardised material and states a concentration — and sometimes it is the same thing at a markup with a nicer bottle. Our dupe finder will tell you which of those you are looking at, and the ingredient decoder will read the panel so you can compare the whole formula rather than the headline. ↗Our Korean skincare ranking assesses formulas rather than novelty, which is the only defence against a conveyor that never stops.